Tackling cancer evolution and resistance in our new Centre for Cancer Drug Discovery 02 Jul 2019 Fiona Want is a second-year PhD student in our Division of Cancer Therapeutics. She is working to understand APOBEC proteins, and help develop what ICR researchers believe will be the world’s first family of drugs to target cancer’s ability to evolve and become resistant to treatment. Fiona will be moving along with her team into the ICR’s new Centre for Cancer Drug Discovery next year, working alongside drug discovery researchers and evolutionary scientists to focus on meeting the pressing challenge of cancer evolution and drug resistance. Find out more Show/Hide